
Meena B Bansal
Hepatology Fellowship Director · Mount Sinai
Credentials: · · · ·
History
- 2002–Present
Hepatology Fellowship Director Fellowship · Mount Sinai
Research
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
New England Journal of Medicine · 2024 · 1,637 citations
The Lancet · 2019 · 640 citations
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
New England Journal of Medicine · 2017 · 434 citations

12 papers

12 papers

11 papers

10 papers

10 papers

10 papers

10 papers

9 papers
Grants
- 2015–2022
HIV and Hepatic Inflammation and Fibrosis
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.1M · Icahn School of Medicine at Mount Sinai
- 2011–2013
Stellate Cell-HIV Interactions and Hepatic Fibrosis
National Institute of Diabetes and Digestive and Kidney Diseases · R56
Contact PI · $368K · Icahn School of Medicine at Mount Sinai
- 2006–2008
Role of Matrix Metalloproteinase-2 in Liver Fibrosis
National Institute of Diabetes and Digestive and Kidney Diseases · R03
Contact PI · $167K · Icahn School of Medicine at Mount Sinai
- 2002–2008
IL-6 Regulation of Matrix Degradation in Liver Fibrosis
National Institute of Diabetes and Digestive and Kidney Diseases · K08
Contact PI · $641.1K · Icahn School of Medicine at Mount Sinai




